Full Text
EE135 Cost-Utility Analysis of Benralizumab in Severe Eosinophilic Asthma in Colombia

Abstract

Authors

J Ordoñez A Ordóñez

Back to Volume 25, Supplemental Issue 7S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×